The American Bar Association’s Section of Intellectual Property Law (ABA-IPL) has named Darrell G. Mottley editor-in-chief of its Landslide magazine. Mr. Mottley previously served as deputy editor-in-chief and moved into his new role
Charles W. Shifley discusses whether inter partes reviews could lead to a decrease in patent applications and litigation in the August 2015 issue of Chicago Lawyer magazine. Please click here to read, “Patently Dangerous: Rise of the
In the July 27 article, Mr. Dannenberg weighs in on a lawsuit filed by the state of Georgia against a political activist for allegedly uploading and distributing copies of its annotated
FEDERAL DISTRICT COURT AFFIRMS CANCELLATION OF “REDSKINS” MARKS ON SUMMARY JUDGMENT AND HOLDS THAT FIRST AMENDMENT DOES NOT CONTROL By Maurine L. Knutsson On July 8, 2015, the Federal District Court
Banner & Witcoff welcomes Benjamin Koopferstock and Javier A. Liceaga to the Washington, D.C., office as associates. Mr. Koopferstock focuses his practice on the preparation and prosecution of patent applications.
FEDERAL CIRCUIT HOLDS CLAIMS INDEFINITE BASED ON PROSECUTION HISTORY IN TEVA PHARMACEUTICALS USA V. SANDOZ, INC. By R. Gregory Israelsen and Shawn P. Gorman On June 18, 2015, the United States Court of
Bradley J. Van Pelt and Brittany M. Martinez discuss how patent holders can prepare for the issue of obviousness in inter partes reviews in their Law360 Expert Analysis article, “Preparing
FEDERAL CIRCUIT CHANGES COURSE AND UPHOLDS LIGHTING BALLAST PATENT FOLLOWING TEVA REMAND By Paul M. Rivard In 2014, in Lighting Ballast Control LLC v. Philips Electronics North America Corp., the Federal Circuit
FEDERAL CIRCUIT CHANGES COURSE AND UPHOLDSLIGHTING BALLAST PATENT FOLLOWING TEVAREMAND By Paul M. Rivard In 2014, in Lighting Ballast Control LLC v. Philips Electronics North America Corp., the Federal Circuit
Mr. Shifley explains in Law360 that the Supreme Court’s decision in Kimble v. Marvel Enterprises allows patent owners and licensees to confidently and without concern extend “in-term” royalties on patents into the post-expiration
